Cytokine effects on cell survival and death of A549 lung carcinoma cells

Cytokine

Volumn 61, Issue 3, 2013, Pages 816-825

  Kastamoulas, Michalis ^a   Chondrogiannis, Georgios ^a   Kanavaros, Panagiotis ^a   Vartholomatos, Georgios ^b   Bai, Maria ^a   Briasoulis, Evangelos ^a   Arvanitis, Dimitrios ^c   Galani, Vasiliki ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Apoptosis; Cytokines; Lung carcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84875375789     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.01.017     Document Type: Article

References (64)

1. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
2. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
3. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002, 2(277):88.
4. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 2004, 116:221-234.
5. Okada H., Mak T.W. Pathways of apoptotic and non-apoptotic cell death in tumor cells. Nat Rev Cancer 2004, 4:592-603.
6. Hersey G.K.K. Il-13 receptors and signalling pathways: an evolving web. J Allergy Clin Immunol 2003, 11:677-690.
7. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
8. Kurdi M., Booz G.W. Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-γ on Fas-induced apoptosis of A549 human non-small cell lung cancer cells. J Interferon Cytokine Res 2007, 27:23-31.
9. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117:1175-1183.
10. Naugler W.E., Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008, 18:19-26.
11. Skinnider B.F., Mak T.W. The role of cytokines in classical Hodgkin lymphoma. Blood 2002, 99:4283-4297.
12. Terabe M., Park J.M., Berzofsky J.A. Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother 2004, 53:79-85.
13. Jemal A., Thun M.J., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use and tobacco control. J Natl Cancer Inst 2008, 100:1672-1694.
14. Atherton H.C., Jones G., Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am J Physiol Lung Cell Mol Physiol 2003, 285:730-739.
15. Babbar N., Hacker A., Huang Y., et al. Tumor necrosis factor alpha induces spermidine/spermine N1-acetyltransferase through nuclear factor kappaB in non-small cell lung cancer cells. J Biol Chem 2006, 281:24182-24192.
16. Berkova N., Lair-Fulleringer S., Féménia F., et al. Aspergillus fumigatus conidia inhibit tumour necrosis factor- or staurosporine-induced apoptosis in epithelial cells. Int Immunol 2005, 18:139-150.
17. Booth B.W., Adler K.B., Bonner J.C., et al. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 2001, 25:739-743.
18. Borowski A., Kuepper M., Horn U., et al. Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts. Clin Exp Allergy 2008, 38:1-10.
19. Chen C.C., Chen J.J., Chou C.Y. Protein kinase calpha but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH(2)-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1beta: involvement of sequential activation of tyrosine kinase, nuclear factor-kappaB-inducing kinase, and IkappaB kinase 2. Mol Pharmacol 2000, 58:1479-1489.
20. Chen C.C., Chou C.Y., Sun Y.T., et al. Tumor necrosis factor alpha-induced activation of downstream NF-kappaB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion: involvement of PKCalpha, tyrosine kinase, and IKK2, but not MAPKs pathway. Cell Signal 2001, 13:543-553.
21. Coulter K.R., Doseff A., Sweeney P., et al. Opposing effect by cytokines on Fas-mediated apoptosis in A549 lung epithelial cells. Am J Respir Cell Mol Biol 2002, 26:58-66.
22. Geiser T., Jarreau P.H., Atabai K., et al. Interleukin-1beta augments in vitro alveolar epithelial repair. Am J Physiol Lung Cell Mol Physiol 2000, 279:1184-1190.
23. Goto K., Chiba Y., Misawa M. IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells. Cytokine 2009, 46:96-99.
24. Hebenstreit D., Luft P., Schmiedlechner A., et al. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J Immunol 2003, 171:5901-5907.
25. Holden N.S., Catley M.C., Cambridge L.M., et al. ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK. Eur J Biochem 2004, 271:785-791.
26. Ip W.K., Wong C.K., Lam C.W. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin Exp Immunol 2006, 145:162-172.
27. Jang C., Lim K.J., Paik J.H., et al. Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells involvement of PI3K, PKC, p38 MAPK, JNK, and NF-κappaB. Biochem Biophys Res Commun 2004, 320:1026-1033.
28. Kim D.M., Koo S.Y., Jeon K., et al. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res 2003, 63:621-626.
29. Lee I.T., Lin C.C., Wu Y.C., et al. TNF-alpha induces matrix matalloproteinase-9 expression in A549 cells: role of TNFR1/TNFR2/PKCalpha-dependent signaling pathways. J Cell Physiol 2010, 224:454-464.
30. Lee P.J., Zhang X., Shan P., et al. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 2006, 116:163-173.
31. Lin C.C., Tseng H.W., Hsieh H.L., et al. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. Toxicol Appl Pharmacol 2008, 229:386-398.
32. Lin F.S., Lin C.C., Chien C.S., et al. Involvement of p42/p44 MAPK, JNK and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells. J Cell Physiol 2005, 202:464-473.
33. Newton R., Cambridge L., Hart L.A., et al. The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes. Br J Pharmacol 2000, 130:1353-1361.
34. Ogura H., Tsukumo Y., Sugimoto H., et al. Ectodomain shedding of TNF receptor 1 induced by protein synthesis inhibitors regulates TNF-alpha-mediated activation of NF-kappaB and caspase-8. Exper Cell Res 2008, 314:1406-1414.
35. Oh J.H., Kwon T.K. With aferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells. Int Immuno Pharmacol 2009, 9:614-619.
36. Pryhuber G.S., Huyck H.L., Staversky R.J. Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2. Am J Respir Cell Mol Biol 2000, 2:150-156.
37. Relova A.J., Kampf C., Roomans G.M. Effects of TH-2 cytokines on human airway epithelial cells: interleukins 4, 5 and 13. Cell Biol Int 2001, 25:563-566.
38. Roberts M.L., Cowsert L.M. Interleukin-1beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases in human epithelial cells, by two independent pathways. Biochem Biophys Res Comm 1998, 251:166-172.
39. Shi Z.O., Fischer M.J., De Sanctis G.T., et al. IFN-gamma, but not Fas, mediates reduction of allergen-induced mucous cell metaplasia by inducing apoptosis. J Immunol 2002, 168:4764-4771.
40. Singhera G.K., MacRedmond R., Dorscheid D.R. Interleukin-9 and -13 inhibit spontaneous and corticosteroid induced apoptosis of normal airway epithelial cells. Exp Lung Res 2008, 34:579-598.
41. Zhao Y., He D., Zhao J., et al. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells. J Biol Chem 2007, 282:10172-10179.
42. Bai L., Yu Z., Wang C. Dual role of TGF-β1 on Fas-induced apoptosis in lung epithelial cells. Respir Physiol Neurobiol 2011, 177:241-246.
43. Dempsey P.W., Doyle S.E., He J.Q., et al. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003, 14:193-209.
44. Lee J.K., Kim S.H., Lewis E.C., et al. Differences in signalling pathways by IL-1beta and IL-18. Proc Natl Acad Sci USA 2004, 101:8815-8820.
45. Wright K., Kolios G., Westwick J., et al. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. J Biol Chem 1999, 274:17193-17201.
46. Darzynkiewicz Z., Bedner E., Smolewski P. Flow cytometry in analysis of cell cycle and apoptosis. Sem Hematol 2001, 38:179-193.
47. Galani V., Constantopoulos S.H., Manda-Stahouli C., et al. Additional proteins in BAL fluid of Metsovites environmentally exposed to asbestos. Chest 2002, 121:273-278.
48. Becker Y. Molecular immunological approaches to biotherapy of human cancers-a review, hypothesis and implications. Anticancer Res 2006, 26:1113-1134.
49. Belardelli F., Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 2002, 23:201-208.
50. Chang F., Lee J.T., Navolanic P.M., et al. Involvement of PI3K/AKT pathway in cell cycle progression, apoptosis and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003, 17:590-603.
51. Chopra D.P., Menard R.E., Januszewski J., et al. TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett 2004, 203:145-154.
52. Chu Z.L., McKinsey T.A., Liu L., et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA 1997, 94:10057-10062.
53. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood 1996, 97:2095-2147.
54. Galani V., Tatsaki E., Bai M., et al. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS): an up-to-date cell-specific review. Pathol Res Pract 2010, 206:145-150.
55. Gaur U., Aggarwal B.B. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003, 66:1403-1408.
56. Hanada T., Yoshimura A. Regulation of cytokine-signaling and inflammation. Cytokine Growth Factor Rev 2002, 13:413-421.
57. Matute-Bello G., Winn R.K., Jonas M., et al. Fas (CD 95) induces alveolar epithelial cell apoptosis in vivo. Am J Pathol 2001, 158:153-161.
58. Nakamura M., Matute-Bello G., Liles W.C., et al. Differential response of human lung epithelial cell to Fas-induced apoptosis. Am J Pathol 2004, 164:1949-1958.
59. Pinto F.C., Menezes G.B., Mouraet S.A., et al. Induction of apoptosis in tumor cells as a mechanism of tumor growth reduction in allergic mice. Pathol Res Pract 2009, 205:559-567.
60. Platanias L.C. Map kinase signaling pathways and hematologic malignancies. Blood 2003, 101:4667-4679.
61. Strieter R.M., Belperio J.A., Keane M.P. Cytokines in innate host defence in the lung. J Clin Invest 2002, 109:699-705.
62. Van Antwerp D.J., Martin S.J., Kafri T., et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
63. Wang C.Y., Mayo M.W., Korneluk R.G., et al. NF-kappaB antiapoptosis: induction of TRAF1, TRAF2, c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
64. Relic B., Guicheux J., Mezin F., et al. IL-4 and IL-13 but not IL-10 protect human synoviocytes from apoptosis. J Immunol 2001, 166:2775-2782.